This Sunday, if Wally Bishop goes out to dinner with his three children to celebrate Father’s Day, he won’t be nervous about whether the restaurant will have adequate seating for him, something he used to worry about on a regular basis. After losing over 200 pounds, Wally can just sit back and enjoy the time with his family. He might even save room for dessert.

If you live in South Carolina you’ve probably passed Wally and his lovely wife on their bikes as they peddle around town. Wally describes himself as an avid cyclist but says there was a time when even walking down the block was a challenge. Like many people, Wally was healthy and active until he graduated high school but then slowly the stress of his job and life in general, coupled with poor diet choices and not enough activity caused the pounds to slowly creep on. To make matters worse, whenever Wally would try to diet, he ended up gaining back more weight than he lost. He wanted to change but yo-yo dieting was sabotaging his efforts. Finally, he came to the conclusion that focusing on the scale was actually part of his problem. That’s when he switched gears.

Read Full Post >

A year-long study regarding the connection between weight loss surgery and curing type 2 diabetes was released this week. The study showed that surgery seemed to be more effective than lifestyle change and medication for treating the disease. However, the tradeoff was that those who had the surgery were at a very common risk for complications. Is this just a one step forward and one step back scenario?

The Associated Press reported that a new publication in the Journal of the American Medical Association is stating that gastric bypass surgery can effectively treat type 2 diabetes in patients with mild to moderate obesity. This means people who are about 50 to 70 pounds overweight.

While the glowing light of the words “treatment for diabetes” seems impressive, it was also stated that of those in the study who received surgery, a third of them developed serious problems during the first year after surgery. The typical complications include infections, intestinal blockage, and bleeding. And then there was a much smaller percentage who experienced much more severe complications.
Read Full Post >

The Affordable Care Act, first disparagingly referred to as Obamacare and now adopted as its accepted moniker, is the most sweeping and dramatic health care legislation since Medicare. It’s also one of the more divisive.

Proponents say it will bring health care costs down through wider preventative care; opponents say it is intrusive and sets us up for a new bloated federal bureaucracy.

One of the most important tasks in preventative care and health care cost-reduction is addressing the obesity epidemic. According to the Centers for Disease Control and Prevention, the direct and indirect medical care costs of obesity in the U.S. in 2008 was $147 billion. While obesity rates have leveled in recent years, long-term projections are still grim, with the possibility of nearly half of all Americans being obese by 2030. One report projects the majority of states will be over the 50 percent level.

While there are many myths about Obamacare, one of the better known facts about the legislation is that it will eliminate insurance companies’ ability to discriminate based on pre-existing conditions. But it’s not the utopian “health care for all” scenario some critics may think. Companies are able to more aggressively reward employees for achieving preset wellness goals, and conversely, saddling those who don’t make an effort to improve their health with higher premiums.
Read Full Post >

Invokana is the newest diabetes drug to hit the market and uses an innovative mechanism to help control blood sugar for type 2 diabetes. Invokana, produced by Janssen Pharmaceuticals, will make a splash in the market as this is the first drug of its kind.

The statistic for this drug that I’m most interested in is the reduction in A1C percentage. Hemoglobin A1C is the percent of glucose that is bound to red blood cells. It also gives a three-month big picture of the patient’s control of their blood sugar. The higher the number the higher the person’s daily blood sugars will be; the goal is to be under seven percent. Trials have shown that Invokana has lowered A1C percent by approximately 1 percent over 26 weeks with a 300 mg dose and a 0.77 percent decrease with a 100 mg dosage. A one-percent reduction is approximately a decrease of 14 points on an average daily blood glucose reading. Lower blood sugars overall will prevent complications which can include blindness, renal failure and amputations.
Read Full Post >

With the United States’ Hispanic population growing in number, it is becoming increasingly important to focus on the health and well-being of that community. Obesity is an epidemic concerning all Americans, but it is an especially concerning one for Hispanics and Mexican Americans who collectively have an obesity rate of about 40%, according to the CDC.

This high rate can be attributed to many factors. Several studies have shown the strong correlation between poverty and obesity. The CDC Health Disparities and Inequalities Report for 2011 found that the greatest racial/ethnic disparity in income and education existed for Hispanics. That there is a higher likelihood for obesity in a lower income situation can be found in both men and women.

However, adults are not the only members of the Hispanic and Mexican-American populations with significantly higher obesity rates. The rate in children is alarmingly high as well – about 23 percent of Hispanic children compared to the 16 percent rating of their Non-Hispanic white counterparts. Reducing obesity in children is particularly important as being overweight at a young age can lead to a litany of health issues.
Read Full Post >